512 related articles for article (PubMed ID: 2478670)
1. Granulocyte colony-stimulating factor stimulates recovery of granulocytes in patients receiving dose-intensive chemotherapy without bone marrow transplantation.
Neidhart J; Mangalik A; Kohler W; Stidley C; Saiki J; Duncan P; Souza L; Downing M
J Clin Oncol; 1989 Nov; 7(11):1685-92. PubMed ID: 2478670
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease.
Taylor KM; Jagannath S; Spitzer G; Spinolo JA; Tucker SL; Fogel B; Cabanillas FF; Hagemeister FB; Souza LM
J Clin Oncol; 1989 Dec; 7(12):1791-9. PubMed ID: 2479719
[TBL] [Abstract][Full Text] [Related]
3. [Effect of recombinant human granulocyte colony stimulating factor (rhG-CSF) in patients receiving chemotherapy--phase I study].
Fukutani H; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nagamine D; Shinagawa K; Tabata M; Hirano A; Mizunuma N
Gan To Kagaku Ryoho; 1989 May; 16(5):2005-12. PubMed ID: 2471461
[TBL] [Abstract][Full Text] [Related]
4. Clinical effects of recombinant human granulocyte colony-stimulating factor in leukemia patients: a phase I/II study.
Teshima H; Ishikawa J; Kitayama H; Yamagami T; Hiraoka A; Nakamura H; Shibata H; Masaoka T; Takaku F
Exp Hematol; 1989 Sep; 17(8):853-8. PubMed ID: 2475358
[TBL] [Abstract][Full Text] [Related]
5. Effects of the in vivo administration of recombinant human granulocyte colony-stimulating factor following cytotoxic chemotherapy on granulocytic precursors in patients with malignant lymphoma.
Ema H; Suda T; Sakamoto S; Tomonaga T; Tsunoda J; Muroi K; Komatsu N; Miwa A; Ohsaka A; Yoshida M
Jpn J Cancer Res; 1989 Jun; 80(6):577-82. PubMed ID: 2474526
[TBL] [Abstract][Full Text] [Related]
6. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats.
Fulton R; Gasper PW; Ogilvie GK; Boone TC; Dornsife RE
Exp Hematol; 1991 Sep; 19(8):759-67. PubMed ID: 1714401
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF.
Laughlin MJ; Kirkpatrick G; Sabiston N; Peters W; Kurtzberg J
Ann Hematol; 1993 Dec; 67(6):267-76. PubMed ID: 7506580
[TBL] [Abstract][Full Text] [Related]
8. Double-cycle high-dose chemotherapy with peripheral blood stem cells and hematopoietic growth factor support in patients with advanced solid tumor. A pilot study by the Hong Kong Biotherapy Group.
Yeung AW; Pang YK; Tsang YC; Wong SW
Cancer; 1994 Apr; 73(7):1960-70. PubMed ID: 7511042
[TBL] [Abstract][Full Text] [Related]
9. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
10. [Clinical application of recombinant human colony-stimulating factor (rhG-CSF) in bone marrow transplantation].
Takahashi S; Kodo H
Rinsho Ketsueki; 1990 May; 31(5):589-96. PubMed ID: 1697628
[TBL] [Abstract][Full Text] [Related]
11. Dose escalation study of recombinant human granulocyte-colony-stimulating factor (KRN8601) in patients with advanced malignancy.
Eguchi K; Sasaki S; Tamura T; Sasaki Y; Shinkai T; Yamada K; Soejima Y; Fukuda M; Fujihara Y; Kunitou H
Cancer Res; 1989 Sep; 49(18):5221-4. PubMed ID: 2475245
[TBL] [Abstract][Full Text] [Related]
12. Concomitant and sequential administration of recombinant human granulocyte colony-stimulating factor and recombinant human interleukin-3 to accelerate hematopoietic recovery after autologous bone marrow transplantation for malignant lymphoma.
Lemoli RM; Rosti G; Visani G; Gherlinzoni F; Miggiano MC; Fortuna A; Zinzani P; Tura S
J Clin Oncol; 1996 Nov; 14(11):3018-25. PubMed ID: 8918500
[TBL] [Abstract][Full Text] [Related]
13. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation.
Brandt SJ; Peters WP; Atwater SK; Kurtzberg J; Borowitz MJ; Jones RB; Shpall EJ; Bast RC; Gilbert CJ; Oette DH
N Engl J Med; 1988 Apr; 318(14):869-76. PubMed ID: 3281007
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human granulocyte colony-stimulating factor accelerates hematopoietic recovery after DLA-identical littermate marrow transplants in dogs.
Schuening FG; Storb R; Goehle S; Graham TC; Hackman R; Mori M; Souza LM; Appelbaum FR
Blood; 1990 Aug; 76(3):636-40. PubMed ID: 1696148
[TBL] [Abstract][Full Text] [Related]
15. [Effect of recombinant human granulocyte colony-stimulating factor (rG-CSF) on chemotherapy-induced neutropenia in patients with lung cancer].
Ohnoshi T; Ueoka H; Kodani T; Kamei H; Kimura I
Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):911-8. PubMed ID: 1693062
[TBL] [Abstract][Full Text] [Related]
16. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression.
Antman KS; Griffin JD; Elias A; Socinski MA; Ryan L; Cannistra SA; Oette D; Whitley M; Frei E; Schnipper LE
N Engl J Med; 1988 Sep; 319(10):593-8. PubMed ID: 3045544
[TBL] [Abstract][Full Text] [Related]
17. Adverse effect on bone marrow protection of prechemotherapy granulocyte colony-stimulating factor support.
de Wit R; Verweij J; Bontenbal M; Kruit WH; Seynaeve C; Schmitz PI; Stoter G
J Natl Cancer Inst; 1996 Oct; 88(19):1393-8. PubMed ID: 8827017
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte-colony stimulating factor (filgrastim) accelerates granulocyte recovery after intensive postremission chemotherapy for acute myeloid leukemia with aziridinyl benzoquinone and mitoxantrone: Cancer and Leukemia Group B study 9022.
Moore JO; Dodge RK; Amrein PC; Kolitz J; Lee EJ; Powell B; Godfrey S; Robert F; Schiffer CA
Blood; 1997 Feb; 89(3):780-8. PubMed ID: 9028308
[TBL] [Abstract][Full Text] [Related]
19. Use of recombinant human hematopoietic growth factors and autologous bone marrow transplantation to attenuate the neutropenic trough of high-dose therapy.
Spitzer G; Deisseroth A; Ventura G; Jagannath S; Fogel B; Taylor K; Huan S; Dunphy F; Dicke K; Souza L
Int J Cell Cloning; 1990 Jan; 8 Suppl 1():249-59; discussion 259-61. PubMed ID: 1691246
[TBL] [Abstract][Full Text] [Related]
20. GM-CSF accelerates neutrophil recovery after autologous bone marrow transplantation for Hodgkin's disease.
Devereaux S; Linch DC; Gribben JG; McMillan A; Patterson K; Goldstone AH
Bone Marrow Transplant; 1989 Jan; 4(1):49-54. PubMed ID: 2647187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]